In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG
Evidence of antibody-dependent enhancement (ADE) of other viruses has raised concerns about the safety of SARS-CoV-2 vaccines and antibody therapeutics. In vitro studies have shown ADE of SARS-CoV-2 infection. In this study, we also found that vaccination/convalescent sera and some approved monoclon...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Pathogens |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/12/9/1108 |
| _version_ | 1797578194688147456 |
|---|---|
| author | Xun Wang Minghui Li Panpan Lu Chen Li Chaoyue Zhao Xiaoyu Zhao Rui Qiao Yuchen Cui Yanjia Chen Jiayan Li Guonan Cai Pengfei Wang |
| author_facet | Xun Wang Minghui Li Panpan Lu Chen Li Chaoyue Zhao Xiaoyu Zhao Rui Qiao Yuchen Cui Yanjia Chen Jiayan Li Guonan Cai Pengfei Wang |
| author_sort | Xun Wang |
| collection | DOAJ |
| description | Evidence of antibody-dependent enhancement (ADE) of other viruses has raised concerns about the safety of SARS-CoV-2 vaccines and antibody therapeutics. In vitro studies have shown ADE of SARS-CoV-2 infection. In this study, we also found that vaccination/convalescent sera and some approved monoclonal antibodies can enhance SARS-CoV-2 infection of FcR-expressing B cells in vitro. However, the enhancement of SARS-CoV-2 infection can be prevented by blocking Fc–FcR interaction through the addition of human serum/IgG or the introduction of mutations in the Fc portion of the antibody. It should be noted that ADE activity observed on FcR-expressing cells in vitro may not necessarily reflect the situation in vivo; therefore, animal and clinical data should be included for ADE evaluation. |
| first_indexed | 2024-03-10T22:18:38Z |
| format | Article |
| id | doaj.art-b067a06a8e124351ae97c0bc5ed5701b |
| institution | Directory Open Access Journal |
| issn | 2076-0817 |
| language | English |
| last_indexed | 2024-03-10T22:18:38Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pathogens |
| spelling | doaj.art-b067a06a8e124351ae97c0bc5ed5701b2023-11-19T12:22:08ZengMDPI AGPathogens2076-08172023-08-01129110810.3390/pathogens12091108In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgGXun Wang0Minghui Li1Panpan Lu2Chen Li3Chaoyue Zhao4Xiaoyu Zhao5Rui Qiao6Yuchen Cui7Yanjia Chen8Jiayan Li9Guonan Cai10Pengfei Wang11Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaReproductive Center, Women and Children’s Hospital, Qingdao University, Qingdao 266001, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaShanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai 200438, ChinaEvidence of antibody-dependent enhancement (ADE) of other viruses has raised concerns about the safety of SARS-CoV-2 vaccines and antibody therapeutics. In vitro studies have shown ADE of SARS-CoV-2 infection. In this study, we also found that vaccination/convalescent sera and some approved monoclonal antibodies can enhance SARS-CoV-2 infection of FcR-expressing B cells in vitro. However, the enhancement of SARS-CoV-2 infection can be prevented by blocking Fc–FcR interaction through the addition of human serum/IgG or the introduction of mutations in the Fc portion of the antibody. It should be noted that ADE activity observed on FcR-expressing cells in vitro may not necessarily reflect the situation in vivo; therefore, animal and clinical data should be included for ADE evaluation.https://www.mdpi.com/2076-0817/12/9/1108antibody-dependent enhancementCOVID-19SARS-CoV-2vaccination serumconvalescent serum |
| spellingShingle | Xun Wang Minghui Li Panpan Lu Chen Li Chaoyue Zhao Xiaoyu Zhao Rui Qiao Yuchen Cui Yanjia Chen Jiayan Li Guonan Cai Pengfei Wang In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG Pathogens antibody-dependent enhancement COVID-19 SARS-CoV-2 vaccination serum convalescent serum |
| title | In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG |
| title_full | In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG |
| title_fullStr | In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG |
| title_full_unstemmed | In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG |
| title_short | In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG |
| title_sort | in vitro antibody dependent enhancement of sars cov 2 infection could be abolished by adding human igg |
| topic | antibody-dependent enhancement COVID-19 SARS-CoV-2 vaccination serum convalescent serum |
| url | https://www.mdpi.com/2076-0817/12/9/1108 |
| work_keys_str_mv | AT xunwang invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT minghuili invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT panpanlu invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT chenli invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT chaoyuezhao invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT xiaoyuzhao invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT ruiqiao invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT yuchencui invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT yanjiachen invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT jiayanli invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT guonancai invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg AT pengfeiwang invitroantibodydependentenhancementofsarscov2infectioncouldbeabolishedbyaddinghumanigg |